BioXcel Therapeutics, Inc. (BTAI) SEC filings
BTAI SEC filings moved a median of -2.14% by the close. BTAI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the BTAI overview →
101 measured BTAI SEC filing events.
Where these BTAI SEC filings landedvs 97 measured BTAI SEC filing reactions
| Middle 50% of BTAI SEC filing reactions | -6.35% to +2.28% |
|---|---|
| Median reaction (to close) | -2.14% |
| Measured reactions | 97 |
Point-in-time · zero look-ahead
Half of the 97 BTAI SEC filing events with a measured close landed between -6.35% and +2.28%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K BioXcel Therapeutics, For: Aug 31 | SEC filing · Form 8-K | -5.79% | -2.14% | |
| Form 8-K BioXcel Therapeutics, For: Aug 27 | SEC filing · Form 8-K | -2.54% | -14.52% | |
| Form 8-K BioXcel Therapeutics, For: Aug 24 | SEC filing · Form 8-K | +2.15% | -5.20% | |
| Form 8-K BioXcel Therapeutics, For: Aug 21 | SEC filing · Form 8-K | -2.06% | -4.92% | |
| Form 10-Q BioXcel Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.91% | +7.21% | |
| Form 8-K BioXcel Therapeutics, For: Aug 10 | SEC filing · Form 8-K | -1.67% | -3.44% | |
| Form 8-K BioXcel Therapeutics, For: Jul 31 | SEC filing · Form 8-K | -0.36% | +4.13% | |
| Form 8-K BioXcel Therapeutics, For: Jul 06 | SEC filing · Form 8-K | -6.67% | -18.52% | |
| Form 10-Q BioXcel Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.28% | -2.56% | |
| Form 8-K BioXcel Therapeutics, For: May 15 | SEC filing · Form 8-K | +1.28% | -2.56% | |
| Form 8-K BioXcel Therapeutics, For: Apr 15 | SEC filing · Form 8-K | -3.28% | -5.74% | |
| Form 8-K BioXcel Therapeutics, For: Apr 15 | SEC filing · Form 8-K | +3.13% | +7.14% | |
| Form 8-K BioXcel Therapeutics, For: Apr 01 | SEC filing · Form 8-K | +1.09% | -10.95% | |
| Form 10-K BioXcel Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.13% | -5.47% | |
| Form 8-K BioXcel Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -5.99% | -11.27% | |
| Form S-8 BioXcel Therapeutics, | SEC filing · Form S-8 | -3.13% | -5.47% | |
| Form 8-K BioXcel Therapeutics, For: Mar 10 | SEC filing · Form 8-K | +0.64% | -1.27% | |
| Form 8-K BioXcel Therapeutics, For: Feb 12 | SEC filing · Form 8-K | -0.01% | -4.94% | |
| Form 8-K BioXcel Therapeutics, For: Feb 04 | SEC filing · Form 8-K | -3.25% | +1.95% | |
| Form 8-K BioXcel Therapeutics, For: Jan 20 | SEC filing · Form 8-K | +5.85% | +0.53% | |
| Form 8-K BioXcel Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -1.74% | +0.50% | |
| Form 8-K BioXcel Therapeutics, For: Dec 12 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q BioXcel Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.55% | -6.56% | |
| Form 8-K BioXcel Therapeutics, For: Nov 12 | SEC filing · Form 8-K | +0.55% | -6.56% | |
| Form ARS BioXcel Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.58% | — | |
| Form DEF 14A BioXcel Therapeutics, For: Dec 12 | SEC filing · Form DEF | -0.58% | — | |
| Form 8-K BioXcel Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +2.12% | +2.66% | |
| Form PRE 14A BioXcel Therapeutics, For: Dec 12 | SEC filing · Form PRE | -3.00% | -5.00% | |
| Form 8-K BioXcel Therapeutics, For: Oct 30 | SEC filing · Form 8-K | -0.48% | -3.81% | |
| Form 8-K BioXcel Therapeutics, For: Oct 14 | SEC filing · Form 8-K | -3.06% | +0.38% | |
| Form 8-K BioXcel Therapeutics, For: Sep 15 | SEC filing · Form 8-K | +3.30% | +5.67% | |
| Form 8-K BioXcel Therapeutics, For: Sep 10 | SEC filing · Form 8-K | -1.39% | -2.22% | |
| Form 8-K BioXcel Therapeutics, For: Aug 27 | SEC filing · Form 8-K | +1.63% | -19.18% | |
| Form 8-K BioXcel Therapeutics, For: Aug 18 | SEC filing · Form 8-K | -3.36% | -17.23% | |
| Form 8-K BioXcel Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -3.69% | +18.87% | |
| Form 10-Q BioXcel Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.56% | — | |
| Form 8-K BioXcel Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -2.54% | — | |
| Form 8-K BioXcel Therapeutics, For: Aug 11 | SEC filing · Form 8-K | +0.47% | +48.84% | |
| Form 8-K BioXcel Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -2.37% | +5.06% | |
| Form 8-K BioXcel Therapeutics, For: Aug 01 | SEC filing · Form 8-K | +0.07% | -16.97% | |
| Form 8-K BioXcel Therapeutics, For: Jul 21 | SEC filing · Form 8-K | +0.00% | -2.58% | |
| Form 8-K BioXcel Therapeutics, For: Jul 15 | SEC filing · Form 8-K | -4.36% | -13.64% | |
| Form 8-K BioXcel Therapeutics, For: May 27 | SEC filing · Form 8-K | -6.30% | -2.11% | |
| Form 10-Q BioXcel Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -5.66% | -6.92% | |
| Form 8-K BioXcel Therapeutics, For: May 12 | SEC filing · Form 8-K | -5.66% | -6.92% | |
| Form S-8 BioXcel Therapeutics, | SEC filing · Form S-8 | -4.38% | +13.87% | |
| Form 8-K BioXcel Therapeutics, For: Apr 03 | SEC filing · Form 8-K | -1.16% | -5.78% | |
| Form 10-K BioXcel Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -7.21% | -0.98% | |
| Form 8-K BioXcel Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -0.08% | -6.20% | |
| Form 8-K BioXcel Therapeutics, For: Mar 20 | SEC filing · Form 8-K | -0.43% | +0.00% | |
| Form 8-K BioXcel Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -4.38% | -14.69% | |
| Form 8-K BioXcel Therapeutics, For: Feb 28 | SEC filing · Form 8-K | +28.10% | +54.96% | |
| Form 8-K BioXcel Therapeutics, For: Feb 06 | SEC filing · Form 8-K | +2.61% | -18.87% | |
| Form 8-K BioXcel Therapeutics, For: Jan 28 | SEC filing · Form 8-K | -4.69% | +0.91% | |
| Form EFFECT BioXcel Therapeutics, | SEC filing · Form EFFECT | +0.88% | +4.99% | |
| Form 8-K BioXcel Therapeutics, For: Jan 15 | SEC filing · Form 8-K | +2.43% | -1.20% | |
| Form S-3 BioXcel Therapeutics, | SEC filing · Form S-3 | -4.92% | +9.03% | |
| Form 8-K BioXcel Therapeutics, For: Jan 07 | SEC filing · Form 8-K | -3.11% | -16.65% | |
| Form DEF 14A BioXcel Therapeutics, For: Jan 28 | SEC filing · Form DEF | -0.01% | +1.11% | |
| Form PRE 14A BioXcel Therapeutics, For: Jan 28 | SEC filing · Form PRE | +1.11% | -9.89% | |
| Form 8-K BioXcel Therapeutics, For: Nov 22 | SEC filing · Form 8-K | -4.00% | -7.24% | |
| Form 8-K BioXcel Therapeutics, For: Nov 21 | SEC filing · Form 8-K | +1.81% | -5.74% | |
| Form 10-Q BioXcel Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.95% | -17.04% | |
| Form 8-K BioXcel Therapeutics, For: Nov 14 | SEC filing · Form 8-K | -1.95% | -17.04% | |
| Form 8-K BioXcel Therapeutics, For: Oct 03 | SEC filing · Form 8-K | +0.75% | -5.12% | |
| Form 8-K BioXcel Therapeutics, For: Sep 16 | SEC filing · Form 8-K | +0.02% | -3.50% | |
| Form 8-K BioXcel Therapeutics, For: Sep 17 | SEC filing · Form 8-K | +2.22% | +4.08% | |
| Form 8-K BioXcel Therapeutics, For: Sep 05 | SEC filing · Form 8-K | -4.26% | -7.69% | |
| Form 8-K BioXcel Therapeutics, For: Sep 05 | SEC filing · Form 8-K | +0.70% | -3.26% | |
| Form 10-Q BioXcel Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.00% | -4.00% | |
| Form 8-K BioXcel Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +2.00% | -4.00% | |
| Form 8-K BioXcel Therapeutics, For: Jul 11 | SEC filing · Form 8-K | +0.64% | -0.80% | |
| Form 8-K BioXcel Therapeutics, For: Jul 16 | SEC filing · Form 8-K | -0.81% | +8.94% | |
| Form 8-K BioXcel Therapeutics, For: Jun 25 | SEC filing · Form 8-K | +1.59% | -6.35% | |
| Form 8-K BioXcel Therapeutics, For: Jun 10 | SEC filing · Form 8-K | +1.15% | +2.10% | |
| Form 10-Q BioXcel Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.61% | +1.10% | |
| Form 8-K BioXcel Therapeutics, For: May 09 | SEC filing · Form 8-K | +2.61% | +1.10% | |
| Form DEF 14A BioXcel Therapeutics, For: Jun 10 | SEC filing · Form DEF | +2.51% | -0.77% | |
| Form DEFA14A BioXcel Therapeutics, | SEC filing · Form DEFA14A | +2.51% | -0.77% | |
| Form 8-K BioXcel Therapeutics, For: Apr 22 | SEC filing · Form 8-K | -3.66% | +4.40% | |
| Form PRE 14A BioXcel Therapeutics, For: Jun 10 | SEC filing · Form PRE | +0.39% | +7.84% | |
| Form 8-K BioXcel Therapeutics, For: Apr 10 | SEC filing · Form 8-K | -1.14% | +0.00% | |
| Form S-8 BioXcel Therapeutics, | SEC filing · Form S-8 | +0.00% | +2.28% | |
| Form 8-K BioXcel Therapeutics, For: Mar 25 | SEC filing · Form 8-K | -0.67% | +0.35% | |
| Form 10-K BioXcel Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +7.31% | +9.62% | |
| Form 8-K BioXcel Therapeutics, For: Mar 12 | SEC filing · Form 8-K | -6.06% | -16.06% | |
| Form 8-K BioXcel Therapeutics, For: Feb 14 | SEC filing · Form 8-K | +3.25% | +26.02% | |
| Form 8-K BioXcel Therapeutics, For: Feb 12 | SEC filing · Form 8-K | -1.57% | -12.75% | |
| Form 8-K BioXcel Therapeutics, For: Feb 07 | SEC filing · Form 8-K | +2.18% | +1.90% | |
| Form 8-K BioXcel Therapeutics, For: Feb 08 | SEC filing · Form 8-K | -3.95% | -17.58% | |
| Form EFFECT BioXcel Therapeutics, | SEC filing · Form EFFECT | +1.35% | +6.56% | |
| Form S-3 BioXcel Therapeutics, | SEC filing · Form S-3 | -0.77% | -3.45% | |
| Form 8-K BioXcel Therapeutics, For: Dec 18 | SEC filing · Form 8-K | +0.31% | -0.93% | |
| Form 8-K BioXcel Therapeutics, For: Dec 12 | SEC filing · Form 8-K | +1.60% | +1.28% | |
| Form 8-K BioXcel Therapeutics, For: Dec 05 | SEC filing · Form 8-K | +0.14% | -3.25% | |
| Form 10-Q BioXcel Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.71% | +20.57% | |
| Form 8-K BioXcel Therapeutics, For: Nov 14 | SEC filing · Form 8-K | +1.71% | +20.57% | |
| Form EFFECT BioXcel Therapeutics, | SEC filing · Form EFFECT | +1.71% | +20.57% | |
| Form RW BioXcel Therapeutics, | SEC filing · Form RW | -2.21% | +8.86% | |
| Form RW WD BioXcel Therapeutics, | SEC filing · Form RW | +1.46% | +7.30% | |
| Form S-3 BioXcel Therapeutics, | SEC filing · Form S-3 | +1.16% | -7.21% |
Keep exploring
More BTAI: earnings → · analyst actions → · BTAI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OHR PHARMACEUTICALS (OHRP) | 393 | 0.00% | 48% |
| ACADIA Pharmaceuticals Inc. (ACAD) | 392 | -0.14% | 43% |
| Karyopharm Therapeutics Inc. (KPTI) | 392 | -0.45% | 45% |
| Rubius Therapeutics, Inc. (RUBY) | 392 | -0.32% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.